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Abstract: Since its first appearance on the market, kiwifruit has become very 
popular in the human diet due to its pleasant taste, low caloric value and high 
content of vitamin C. However, kiwifruit allergy has become a frequent cause 
of type I hypersensitivity in the western society. The molecular basis for 
kiwifruit allergy has been ascribed to up-to-now 11 identified IgE reactive 
molecules. They are proteins and glycoproteins with a molecular mass between 
10 and 50 kDa. The major kiwifruit allergen is a cysteine protease denoted as 
Act d 1, which represents 50 % of the soluble protein extract. Due to diffe-
rences in the abundance of the protein components and biological activity, the 
quality of kiwifruit extracts intended for allergy diagnosis can vary in content 
and amount of IgE reactive molecules. In addition, the quality of allergen ex-
tracts for allergy diagnosis depends on the fruit ripening stage and storage 
conditions. In terms of clinical reactivity, it has become evident that kiwifruit 
allergy is not a homogeneous disorder. Different patterns of IgE reactivity ac-
company several clinical subgroups that have been identified in different geo-
graphical regions. In the last decade, enormous progress has been made in the 
isolation and characterization of kiwifruit allergens. This paper presents an 
overview of the structural features of kiwifruit allergens.  
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1. INTRODUCTION 
Since its first appearance on the fruit market, kiwifruit has become very 
popular in the human diet due to its pleasant taste, low caloric value and high 
content of vitamin C; and numerous investigations on health-promoting proper-
ties of this fruit have been reported.1,2 Kiwifruit has also found extensive appli-
cation in the food industry as a meat tenderizer,3 milk coagulant4 and fruit in-
gredient in jams and jellies, syrups, confectionery, etc.5  
However, simultaneously, kiwifruit is a good example of the possible con-
sequences encountered by the introduction of a novel item into the human diet. In 
30 years, from the first report of allergic reaction in 1981,6 kiwifruit has become 
one of the top ten sources of food allergy, as shown in recent studies from Fin-
land, Sweden and France.7 
Kiwifruit was formally described for the first time in 1847 and given the 
Latin name Actinidia chinensis. The plant is native to the Yangtze valley of 
southeast China and has been a favorite of the local population for centuries.8 
The transformation of a small, hard, and wild Chinese berry into the fleshier, 
tastier kiwifruit began in 1904 when a school teacher from New Zealand arrived 
back from a short visit to China with seeds of what was then called Chinese or 
Ichang gooseberry, and from these a local nurseryman produced two plants from 
which almost all today’s cultivars outside of China descend. Kiwifruit benefited 
from the warm, humid climate and volcanic soil of New Zealand’s north island 
and soon became popular in the area, in the beginning valued more as a decora-
tive vine with snowy white flowers than for its fruit. Over the next three decades, 
gardeners developed superior kiwifruit vines through careful selection, pruning, 
and grafting. During World War II, American soldiers stationed in New Zealand 
developed a liking for the taste of this fruit and in 1962, when New Zealand began 
with the export of this fruit to the USA, as part of a marketing campaign, they re-
named it from Chinese gooseberry to kiwifruit, after the national bird of New 
Zealand.9,10 
Kiwifruit belongs to the large genus of Actinidia and was first known under 
the botanical name A. chinensis. However, this species was discovered to be 
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polymorphic comprising several varieties (var. chinensis, var. hispida and var. 
setosa). In 1986, it was concluded that enough differences between the varieties 
exist to reclassify A. chinensis var. chinensis and A. chinensis var. hispida into 
two different species. Kiwifruit that is commercially grown and readily available 
worldwide is now known under the botanical name A. deliciosa (A. Chev) C.F. 
Liang & A.R. Ferguson var. deliciosa.11 Until 1999, the world kiwifruit pro-
duction was mostly based on the green-fleshed cultivar Actinidia deliciosa cv 
Hayward, when the yellow-fleshed cultivar A. chinensis cv Hort16A became 
available on the international market under the commercial name Zespri Gold. 
These two varieties not only differ in taste, but also in their allergenicity. 
2. CLINICAL MANIFESTATIONS OF KIWIFRUIT ALLERGY 
Since it was first described in 1981,6 kiwifruit allergy has been observed 
with increasing frequency in western populations.12 Symptoms of kiwifruit al-
lergy vary from mild symptoms localized to the oral mucosa to severe systemic 
reactions, particularly in young children.12 Kiwifruit allergy can be the result of 
cross-reactivity with pollen and latex, the most frequent association being with 
birch and grass pollinosis;13 however, monosensitizations have also been re-
ported. Symptoms severity and sensitization patterns of kiwifruit allergy are geo-
graphically dependent, with different allergen sensitization patterns seen across 
Europe. More severe symptoms to kiwifruit allergy in allergic patients were re-
corded in the birch-free Mediterranean area than in central Europe.14 Aleman et 
al. provided evidence that kiwifruit allergy is not a homogeneous disorder because 
several clinical subgroups can be established.15 
Food allergy is a consequence of primary sensitization of the immune system 
to food allergens or from primary sensitization to inhalant allergens (pollens or 
latexes in allergies to plant foods) in atopic persons. It has been postulated that 
direct sensitization by food allergens via the oral route is only possible when the 
allergens possess resistance to proteolysis in the digestive tract. This feature is 
regarded as decisive for the potential of food allergens to induce severe systemic 
reactions mediated by immunoglobulin E antibodies.  
Structural similarities of proteins from different sources provide an expla-
nation for a number of clinically observed cross-reactivity cases.13 Due to cross-
reactivity between plant and pollen allergens, patients with allergy to pollens 
often report oral allergy syndrome (OAS) after ingestion of certain fruits, nuts 
and vegetables. Pollen–food cross-reactive IgE antibodies are usually implicated 
in mild symptoms of allergy, such as OAS. The major birch pollen allergen Bet v 
1 and the pollen profilins, the major source of cross-reactive IgE binding epi-
topes, are sensitive to pepsin digestion, and therefore the clinical symptoms of 
allergy are restricted to the oral cavity.  
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3. MOLECULAR BASIS OF KIWIFRUIT ALLERGY 
The molecular basis of kiwifruit allergy is attributed to eleven International 
Union of Immunological Societies (IUIS) nominated kiwifruit allergens (www. 
allergen.org) (Table I). 
TABLE I. Kiwifruit allergens 
Allergen Biochemical name MW / kDa (SDS–PAGE) 
Act d 1  Cysteine protease (actinidin) 30 
Act d 2  Thaumatin-like protein 24 
Act d 3 – 40 
Act d 4  Phytocystatin 11 
Act d 5  Kiwellin 26 
Act d 6 Pectin methylesterase inhibitor 18 
Act d 7 Pectin methylesterase 50 
Act d 8 Pathogenesis-related protein PR-10 17 
Act d 9 Profilin 14 
Act d 10 Lipid transfer protein 1 10 
Act d 11 Major latex protein/ripening-related protein family 17 
3.1. Act d 1 
Actinidin (EC 3.4.22.14) is a cysteine protease from the papain superfamily 
and is abundant in kiwifruit.16 Beginning from the 1970s, this enzyme has been 
studied in detail and its 3-dimensional structure, amino acid and nucleotide se-
quences are known.17–19 The mature form of actinidin is comprised of a single 
polypeptide chain organized into two domains with 3 disulphide bridges and has 
a molecular weight of 23.8 kDa and a pI value of 3.5.17,20,21 Nieuwenhuizen et 
al. identified more than 10 different mRNA molecules encoding actinidin 
isoforms with predicted pI values ranging from acidic (3.9) to basic (9.3).22 Acti-
nidin has a wide pH activity range (4–10) and wide substrate specificity, prefe-
rentially hydrolyzing the amide and ester bonds at the carboxyl side of lysine 
residues.23,24  
Actinidin represents more than 50 % of total soluble protein content in the 
green-fleshed kiwifruit cultivar (A. deliciosa cv. Hayward), but this protein ap-
pears to be at a very low level in Hort16A, the most important commercial cul-
tivar of gold kiwifruit (A. chinensis).16,22 Immunolocalization showed that actini-
din was present inside the vacuole of the small cells of the outer pericarp of ma-
ture A. deliciosa fruit at harvest.22 Several other cysteine proteases, which are 
actinidin homologues from the papain family, are also accumulated at high levels 
in specific tissues or cell types, including papain from papaya, bromelain from 
pineapple and ficin from fig. 
The physiological role of these enzymes is unknown, but it has been pro-
posed that they function as storage proteins or are part of a defense mechanism 
against insects, plant diseases and other forms of stress.25,26 
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Actinidin (Act d 1) is a kiwifruit allergen and is considered a marker of 
monosensitization to this allergen food source, since no cross-reactivity with 
birch or grass pollen has been observed.15,20,27,28 In most studies, actinidin was 
identified as a major allergen in kiwifruit allergic patients.7,25,27–29 An exception 
to this was a study performed in 2007 by Lucas et al. on kiwifruit allergic pati-
ents in the United Kingdom in which none of the 30 patients showed IgE binding 
to purified actinidin in Western blot.30 Actinidin retains allergenicity after ther-
mal treatment, a significant feature in terms of the possible development of aller-
gic reactions after the consumption of food products containing processed kiwi-
fruit.21  
Although some studies indicate that actinidin is susceptible to degradation 
upon passage through the gastrointestinal tract,31 others showed that actinidin 
retains its enzymatic activity under conditions of gastric and intestinal digestion 
and aids in the digestion of food proteins.32,33 In a 2012 study by Čavić et al., the 
proteolytical activity of actinidin, which leads to changes in the morphology and 
adhesion of intestinal epithelial cells, was proposed as a possible route for oral 
sensitization to this allergen.34 
3.2. Act d 2 
The second IgE binding molecule isolated from A. deliciosa was a thau-
matin-like protein (TLP) and it was denominated Act d 2.13 Act d 2, as well as 
other TL proteins, belongs to the pathogenesis related (PR) 5 family of pro-
teins.35 It is a protein of 225 amino acids, with the first 24 representing a signal 
peptide that designates this protein to the apoplast. It has basic pI values of 9.4 
and 9.5.13,14 A potential N-glycosylation site is located on N189FS and glycosy-
lation was suggested to exist based on its ability to bind to concanavalin A lec-
tin.13 Kiwi TLP, similar to other members of the PR 5 family, possesses anti-
fungal activity against Botrytis cynerea, Mycosphaerella arachidicola36 and Sa-
ccharomyces carlsbergensis.13 The anomalous migration of kiwifruit TLP in 
SDS–PAGE is due to an unusually high number of S–S bridges, a peculiarity 
common for TLPs.13 Namely, it has 8 disulphide bridges between cysteines 
Cys33–Cys224, Cys74–Cys84, Cys89–Cys95, Cys140–Cys213, Cys146–Cys196, 
Cys154–Cys164, Cys168–Cys177 and Cys178–Cys183.  
There are opposing studies concerning TLP stability under simulated gastro-
intestinal conditions.13,31 The first obtained results suggested that purified TLP 
was digested in simulated gastric fluid (SGF) in only 1 min, while TLP in crude 
extract resisted digestion for 8 min.13 However, later studies suggested that the 
stability of TLP during simulated gastrointestinal digestion largely depended on 
the enzyme:substrate ratio employed in the experimental setting, as well as whether 
reducing or non-reducing conditions were employed for SDS–PAGE analysis of 
the reaction mixture. Under non-reducing conditions, 25 % of the allergen re-
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mained intact following in vitro gastric digestion and during duodenal digestion 
residual intact Act d 2 was still present when analyzed by SDS–PAGE. Under 
reducing conditions, the allergen promptly disappeared.31 The observed differen-
ces stem from the different digestion protocols used in the experiments, i.e., dif-
ferent amounts of pepsin used for the simulated in vitro digestion. However, it 
can be assumed, as suggested by a later study31 and by similar results obtained 
for milk37 and wheat38 allergens, that disulfide bonds are important in the resis-
tance of this and other allergens to digestion with proteases commonly en-coun-
tered in the gastrointestinal tract. 
Thermal stability experiments suggest that Act d 2 aggregates following 
heating at pH 7, but not at pH 2.31 These results show that cross-linking of Act d 
2 molecules at pH 7 by intermolecular disulfide bonds was induced by heating. 
The cleavage of disulfide bonds at neutral pH and high temperature was pre-
viously observed for thaumatin,39 but also in unrelated proteins including oval-
bumin and transferrin.40 The most probable mechanism of this reaction is β-eli-
mination, in which a base-catalyzed subtraction of a β-proton from a cysteine re-
sults in cleavage of disulfide bonds. This creates intermolecular disulfide link-
ages and induces aggregation. In contrast, thermal denaturation at acidic con-
ditions (such as those found in juice) reversibly unfolded the protein.31 
Members of the TLP family have a role as allergens in a wide panel of plant 
foods and in several pollens, although there is little experimental evidence of 
plant foods and/or pollen cross-reactivity. Gavrović-Jankuović et al.13 showed 
positive skin prick tests (SPT) in 80 % of the tested polysensitized patients (4 out 
of 5) and IgE reactivity in Western blot (7 out of 7 in crude extract). In a study by 
Palacin et al.,14 in vitro (specific IgE detected in 64 % and 88 % of individual 
sera by ELISA and immunodetection assays, respectively) and in vivo (52 % of 
positive SPT responses) reactivity pointed to Act d 2 as the second major aller-
gen in the analyzed kiwi-sensitized population of Spain. Immunoblotting expe-
riments by Bublin et al., showed that in extracts prepared from kiwifruit jam and 
whey, Act d 2 was present and its allergenic activity was not decreased by 
technological treatments.31 
3.3. Act d 3 
Act d 3 is a strongly glycosylated 40 kDa protein present in two genetic va-
riants, and is homologous to hypothetical hydrolases from castor bean and other 
plant species.14,41 The high sequence identity with the putative Ricinus com-
munis protease suggests a functional role for Act d 3 in kiwifruits that could ex-
plain the presence in preparations of the purified allergen of possible self-de-
gradation products that retain IgE-binding potency.14  
Act d 3.02 seems to be a minor component of kiwifruit extracts, yet, in con-
trast, it represents a major kiwi allergen based on its high specific IgE prevalence 
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(62 %) in sera from kiwi-sensitized patients. The potential clinical relevance of 
Act d 3 was further supported by the statistical correlation between IgE levels to 
this allergen and anaphylactic symptoms. All these data are in agreement with 
those observed previously for Act d 3.01, both in vitro (66 % of sera with spe-
cific IgE) and in vivo (13 out of 15 patients with positive SPT responses).41 
Moreover, Act d 3 could probably correspond to the 38-kDa protein described by 
Lucas et al. as the major kiwifruit allergen in the United Kingdom.30 Thirty six 
percent of the 22 patients with combined kiwifruit/pollen or kiwifruit/pollen/latex 
allergy were sensitized to Act d 3, as reported by Bublin et al.29 Moreover, these 
authors claimed that IgE binding to highly cross-reactive allergens (rAct d 8, 
rAct d 9) or Act d 3 was not a clinically specific marker for kiwifruit allergy in 
the presence of pollen or pollen/latex sensitization.29 
The complex glycans (cross-reactive carbohydrate determinants) attached to 
Act d 3 can be a source of cross-reactivity between kiwifruit and other plant foods 
and pollens, the actual clinical relevance of which remains to be explored.14 
3.4. Act d 4 
Act d 4 is a 11 kDa allergen first reported as an IgE binding component of 
kiwifruit extract.28 It belongs to the family of cysteine proteinase inhibitors (CPI) 
named phytocystatins.42 There are 3 isoforms of phytocystatins present in kiwi-
fruit, with isoform 1 being the most abundant.42 Act d 4 was identified and iso-
lated as isoform 1.43  
Act d 4 is a type I plant cystatin synthesized as a pre-protein of 116 amino 
acids, with the first 26 amino acids representing a signal sequence that is cleaved 
off from the mature protein.42,43 Immuno-tissue print results indicated that CPI is 
most abundant in the outer layer of the pericarp, near the peel and the innermost 
part of the pulp – sites where it could act as a natural barrier against pathogens 
entering the fruit.44 It is a glycoprotein with a pI of 6.9 which binds Con A lectin, 
mannose-specific banana lectin and fucose-specific Aleuria aurantia lectin.43 
The molecular masses of the mature protein were determined by MALDI to be 
10902.5 Da and 11055.2 Da.43 These different masses observed could probably 
be attributed to the presence of different glycosylation isoforms present in kiwi-
fruit.  
Act d 4, similar to other type I plant cystatins, showed antifungal activity 
against two phytopathogenic fungi (Alternaria radicina and B. cinerea), by inhi-
biting fungal spore germination. In vivo, Act d 4 was able to prevent artificial 
infection of apple and carrot with spore suspensions of B. cinerea and A. radi-
cina, respectively. It also exerted activity on both intracellular and fermentation 
fluid proteinases.44 Act d 4 influenced the growth of phytopathogenic bacteria 
Agrobacterium tumefaciens (76.2 % growth inhibition using 15 μM CPI), Burk-
holderia cepacia (75.6 % growth inhibition) and, to a lesser extent, Erwinia ca-
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rotovora (44.4 % growth inhibition) by inhibiting proteinases that are excreted by 
these bacteria.45 
Act d 4 was first identified as an IgE binding component of kiwifruit ex-
tract.28 However, a positive skin prick reactivity with Act d 4 was induced in 
three kiwifruit allergic patients, as well as the upregulation of CD63 and CD203c 
molecules in the basophile activation assay. IgE reactivity was detected in dot 
blot analysis and subsequent negative Western blot analysis using sera from six 
kiwifruit patients, which suggested the presence of conformational IgE epitopes 
on the Act d 4 molecule. As an activator of effector cells in type I hypersensi-
tivity Act d 4 is a functional allergen contributing to the clinical symptoms of ki-
wifruit allergy.43 
3.5. Act d 5 
The fifth allergen detected in kiwifruit extract was named kiwellin and was 
designated as Act d 5.46 Kiwellin was first identified in green kiwifruit and 
described as an allergen and one of the major protein components of this fruit.46 
It was also identified in the gold kiwifruit species, where it appears as the most 
abundant protein component.47 Anomalous behavior of Act d 5 was observed in 
SDS-PAGE (traveling as a 20 kDa band in non-reducing and a 28 kDa band in 
reducing conditions), which, as observed for TLP, is a consequence of disulphide 
bridges, as it contains 14 cysteine residues. It contains 189 amino acid residues 
and sequence heterogeneity was found at position 61, where His replaced Tyr in 
approximately 40 % of the protein molecules. 
Kiwellin is cleaved into the following four peptides: kissper, KiTH1, KiTH2 
and KiTH 3.47 Kissper is a 39-residue peptide isolated in good yield from the 
edible part of kiwifruit; its amino acid sequence showed 100 % identity with the 
first 39 residues of the N-terminal region of kiwellin.48 Kissper is derived from 
the processing of the precursor kiwellin through the cleavage of the peptide bond 
between Thr39 and Thr40. The capacity of kissper to permeabilize synthetic 
membranes was tested, and while kissper showed anion selectivity,48 it was at 
concentration values generally lower than those reported for several pore-forming 
peptides, such as defensins, thionins, cecropins, cryptidin, duramycin, etc.49,50 The 
high amount of kissper found in ripe kiwi fruit and its strong resistance to pro-
teolysis suggest that it could very likely affect the gastrointestinal physiology.48  
KiTH was detected on SDS–PAGE as a 20-kDa band. Elucidation and anal-
ysis of the primary structure of purified KiTH revealed 100 % amino acid se-
quence identity with the C-terminal region (residues 40–189) of kiwellin. KiTH 
and kissper were isolated from green kiwifruit in approximately stoichiometric 
amounts, which suggested that both were produced following a proteolytic cleav-
age of kiwellin.47 KiTH and kissper were not detected in gold kiwifruit extract, 
but it cannot be excluded that they were present in very low, undetectable 
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amounts.47 The observation that their presence in green kiwifruit was correlated 
with a high amount of actinidin suggested a possible involvement of this protease 
in their generation. Two KiTH forms found in the green kiwifruit extracts de-
rived from in vivo cleavage between Thr39 and Thr40 (site 1) and between His41 
and Ser42 (site 2) of kiwellin, were also identified as products of in vitro di-
gestion by actinidin. A third form of KiTH, showing two additional residues at 
the N terminus, was obtained after in vitro enzymatic cleavage of kiwellin, sug-
gesting a significant effects of the environmental conditions on the specificity of 
the proteolytic action. The experimental data demonstrated that KiTH and kissper 
are produced following in vitro proteolytic processing by actinidin and that envi-
ronmental conditions may affect the ratio of the digestion products.47 
Serological tests and Western blot analysis showed that kiwellin is speci-
fically recognized by IgE of patients allergic to kiwifruit.46 Similar to kiwellin 
from green kiwifruit,46 the homologous protein from gold kiwifruit displays IgE-
binding capacity. Both proteins were detected by the same sera, and even the 
levels of the signal on Western blot were comparable, thus suggesting conser-
vation of the IgE-binding epitopes. KiTH was also detected as an IgE binding 
molecule.47 The obtained results suggested that (i) kiwellin may have a hidden 
IgE-binding epitope that becomes available in KiTH, following the removal of 
kissper, and (ii) kissper might be an IgE-binding epitope by itself.47  
On testing a population of subjects allergic to kiwifruit using the standard 
protocol for SPT, eight out of 29 (28 %) had a positive reaction to Act d 5. The 
observation that some subjects had a positive reaction either at neutral or acidic 
pH values suggests that this allergen, depending on the experimental conditions, 
may expose different epitopes. CD measurements under different experimental 
conditions indicated that the three-dimensional structure of Act d 5 is modulated 
by the solvent pH and polarity. Therefore, it may be hypothesized that, depend-
ing on the environments encountered, this allergen may undergo in vivo confor-
mational changes and expose different epitopes, inducing the synthesis/inter-
action of different specific IgEs.51 
3.6. Act d 6 
A protein acting as a powerful inhibitor of plant pectin methylesterase 
(PMEI) was isolated from kiwifruit and denoted as Act d 6.52 This protein is 
comprised of 152 amino-acid residues, accounting for a molecular mass of 16277 
Da, with a predominant alpha-helix conformation in the secondary structure.52 
The protein has five cysteine residues but neither tryptophan nor methionine.52 
Analysis of fragments obtained after digestion of the protein alkylated without 
previous reduction identified two disulfide bridges connecting cysteines Cys9– 
–Cys18, and Cys74–Cys114, while Cys140 bears a free thiol group. A database 
search indicated a similarity between PMEI and plant invertase inhibitors. In 
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particular, the four Cys residues, which in PMEI are involved in the disulfide 
bridges, are conserved. A comparison of the sequence of these inhibitors con-
firms the existence of a novel class of proteins with significant sequence conser-
vation, comprising plant proteins acting as inhibitors of sugar metabolism enzy-
mes, and probably involved in various steps of plant development.52 
Considering that PMEI interacts with pectin methylesterase (PME), which is 
localized in the cell wall, it is probable that a signal sequence is required to direct 
the protein toward its final cellular localization. In fact, preliminary experiments 
of tissue immunological staining indicate that Act d 6 is concentrated in a layer 
close to the cell membrane.52 
The relative expression levels of the PMEI genes in kiwifruit, analyzed by 
competitive PCR, increased with progression of fruit maturation. Given that the 
PME activity also showed its highest level at the fully ripened stage of matu-
ration, the increase in PMEI expression may not indicate direct inhibitory effects 
on the PME activity and fruit maturation process.53 
3.7. Act d 7 
Act d 7 belongs to the family of pectin methylesterases (PME), a class of 
proteins involved in pectin metabolism during different physiological and patho-
logical processes, such as fruit ripening54 and response to pathogen attack.55 
PME was purified from a salt extract of kiwifruit cell wall by a combination of 
ion exchange and affinity chromatography (on pectin methylesterase inhibitor 
PMEI).56 PME consists of two forms (PME1 and PME2). Both isoforms have a 
neutral pI of 7.3.56 The molecular weight of purified kiwi PME, determined by 
both gel filtration and SDS–PAGE, was 50 kDa.56 Act d 7 is a monomeric pro-
tein.56 Kiwi PME was reported to be glycosylated with a molecular mass of 57 
kDa,57 however in this case, glycosylation may approximately account for 30 % 
of the total molecular mass of the protein.58 The two isoforms of PME differ in 
their degree of glycosylation as shown by different retention times on conca-
navalin A–sepharose with respect to a glucose gradient.57 
Kiwi PME showed two activity optima at pH 6.5 and 8.0–8.5, both in the 
presence and in the absence of 100 mM NaCl. The enzyme has a pH and salt 
dependent activity. It shows lowered activity at the lower pH optimum in the ab-
sence of salt, which may be due to the adverse effect of specific charged groups 
on the enzyme/substrate interaction.58 The two isoforms also differ in thermosta-
bility, with PME1 being more stable than PME2.57  
Binding experiments, performed by surface plasmon resonance, showed that 
PMEI strongly interacts with immobilized kiwi PME, as indicated by the extre-
mely low dissociation rates observed at pH values ranging from 3.5 to 8.0.58 The 
observation that only extreme pH conditions can dissociate the complex kiwi 
PME–PMEI may address the hypothesis that, in vivo, kiwi PME is irreversibly 
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inactivated by PMEI when it has no further physiological function at the end of 
the ripening process.58  
In Western blot analysis, 13 % of patients had a positive IgE directed to 
purified allergen. Patients positive to Act d 7 were also positive to Api g 5, Ana c 
2 and Hev b 4, which are known as allergens containing cross-reactive carbohyd-
rate determinants (CCDs).59 This can be explained by the high cross reactivity of 
CCDs from different allergen sources.7  
3.8. Act d 8 
Act d 8 is a homologue to the major birch pollen allergen Bet v 1.60 Act d 8 
(from A. deliciosa) and Act c 8 (from A. chinensis) are encoded by open reading 
frames (ORFs) of 471 and 474 nucleotides, corresponding to 157 and 158 amino 
acid residues, respectively.61 There are thirteen ORF sequences corresponding to 
Act d 8 isoforms detected in green kiwi extract, while six were detected in gold 
kiwi extract.61 The amino acid sequence identity between Act d 8 and Act c 8 
was 70 % and to Bet v 1 (CAA54696) 53 and 54 %, respectively.61 The predicted 
molecular masses of Act d 8 and Act c 8 are 16922 Da and 17387 Da, and their 
calculated pI values are 5.36 and 5.82, respectively.61 
Transcripts for Act c 8 and Act d 8 are considerably less abundant, with Act 
c 8 appearing to be more highly expressed than Act d 8 in both green and gold 
kiwifruit.61 
The secondary structures of recombinantly produced Act d 8 and Act c 8 
were determined by CD spectroscopy and the spectra were similar to CD spectra 
obtained with rBet v 1.0101.61  
IgE binding of purified rAct d 8 and rAct c 8 was confirmed in both ELISA 
and immunoblot experiments on the sera from eight kiwifruit/birch pollen 
allergic patients. Both purified proteins were able to bind IgE from patient sera in 
both ELISA and immunoblot. The cross-reactivity of rBet v 1.0101, rAct d 8, and 
rAct c 8 was assayed in an IgE ELISA inhibition assay. Pretreatment of the sera 
from individual kiwifruit/birch pollen allergic patients with rAct d 8 or rAct c 8 
as inhibitor resulted in reduced IgE binding to rBet v 1.0101, while IgE binding 
to rAct d 8 and rAct c 8 was completely inhibited by pre-incubation with rBet v 
1.0101.61  
The results of the localization studies show that a Bet v 1-related protein was 
recognized in the peripheral pulp by a polyclonal anti-Bet v 1 antibody in green 
and gold kiwifruit.61 
Allergic symptoms elicited by a member of the Bet v 1 family are usually 
confined to the oral mucosa or angioedema of the lips. Such mild symptoms have 
been described in Bet v 1-mediated fruit allergy to apple62 and cherry.63 These 
findings could be explained by heat liability and low resistance to digestion of 
the Bet v 1 homologous proteins. 
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Birch pollen-related food allergy is highly prevalent and often perennial. 
Recent study has shown that high food allergen-specific IgG4/IgE ratios seem 
associated with food tolerance, potentially because specific IgG4 blocks IgE 
binding to food allergens. Thus, the presence of food allergen-specific IgG4 
antibodies is no diagnostic marker for birch pollen-related food allergy.64 
3.9. Act d 9 
Act d 9 or profilin is an actin-binding protein involved in the dynamic turn-
over and restructuring of the actin cytoskeleton.65 It is found in all eukaryotic 
organisms in most cells. Profilin is important for spatially and temporally con-
trolled growth of actin microfilaments.65  
Profilin binds sequences rich in the amino acid proline in diverse proteins. 
While most of profilin in a cell is bound to actin, profilins have over 50 different 
binding partners. Many of these are related to actin regulation, but profilin also 
seems to be involved in activities in the nucleus, such as mRNA splicing.66 
Profilin binds some variants of membrane phospholipids. The function of this 
interaction is the sequestration of profilin in an “inactive” form, from where it 
can be released by action of the enzyme phospholipase C. IgE reactive profilins 
are present in birch,67 grass68 and other pollen.69–71 
A primary structure comparison of Act d 9 and profilins from other allergen 
sources revealed amino acid sequence identity with Cap a 2 from bell pepper (93 
%), Hev b 8 from latex (90 %) and Bet v 2 from birch pollen (75 %). 
rAct d 9 demonstrated IgE binding reactivity in vitro in 36 % patients with 
combined kiwifruit/pollen or kiwifruit/pollen/latex allergy.29 
3.10. Act d 10 
Act d 10 belongs to the family of plant lipid transfer proteins or LTPs.72 
Plant LTPs are widely distributed, structurally related, small proteins involved in 
defense mechanisms. Although their lipid binding ability has been well reported, 
the biological function of LTPs is still largely unknown. The plant LTP family 
includes two subfamilies according to their molecular masses: the 9-kDa LTP1 
and the 7-kDa LTP2. Although LTP1 and LTP2 share a common compact fold 
consisting of four α-helices stabilized by four disulfide bridges, the pairing part-
ners of cysteines are not completely conserved between the two subfamilies, that 
also display a low overall sequence similarity (about 30 % identity).73 To date, 
63 LTPs have been characterized as allergens, 46 of them expressed in edible 
parts of plants, almost all of them belonging to the LTP1 protein subfamily, and 
just two to the LTP2 subfamily (www.allergome.org).  
LTP was detected and purified in both gold and green kiwifruit as Act c 10 
and Act d 10, respectively. Both proteins are present in seed extract, but not in 
pulp extract.72 Direct protein sequencing of the purified protein allowed the 
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identification of two different isoforms of Act d 10. Possible additional isoforms, 
suggested by elution profiles obtained during purification, were not identified 
probably because of the low yield.72 
MALDI–TOF mass spectrometry of purified nAct d 10 provided two mass 
values, 9.464 and 9.484 kDa, which are in good agreement with the values 
deduced from the amino acid sequence of the two isoforms having alanine (9.458 
kDa) or threonine (9.488 kDa) as N-terminal residues, respectively.72 
Analysis by SDS–PAGE and RP-HPLC of LTP samples subjected to diges-
tion in SGF showed that nAct c 10 and nAct d 10, similarly to nPru p 3, are re-
sistant to gastric digestion. Moreover, similar to the results reported by Cavatorta 
et al.,74 Pru p 3 was partially digested by trypsin, whereas nAct d 10 and nAct c 
10 appeared to be resistant.72  
A homology search in Uniprot protein database realized using the BLAST 
algorithm (www.expasy.org) showed the sequence identity between Act d 10 and 
other already known allergenic LTPs to be not very high, ranging between 55 % 
with Ara h 9 (isoform Ara h 9.0201) and 35 % with Par j 2. The identities among 
the full-length amino acid sequence of the six allergenic LTPs: Act d 10, Ara h 9, 
Art v 3, Cor a 8, Mor n 3 and Pru p 3 are in the range from 42 to 70 %. The 
sequence identity values between Act d 10 and other allergenic LTPs, such as 
Api g 2 (celery stalk), Cit s 3 (orange), Fra a 3 (strawberry), Lac s 1 (lettuce), 
Len c 3 (lentil), Lyc e 3 (tomato), Mal d 3 (apple), Ory s 14 (rice), Pla or 3 (plane 
tree pollen), Pru du 3 (almond), Pyr c 3 (pear), Sin a 3 (mustard), Tri a 14 
(wheat), Vit v 1 (grape), Zea m 14 (maize) are found in the narrow range of 
40–55 %.72  
3.11. Act d 11 
Act d 11 is a 17-kDa protein found in variable amounts in extracts of green 
kiwifruit. This is a ripening-related protein, the amount of which is influenced by 
natural ripening and post harvesting treatments, including exposure to the plant 
hormone ethylene.75 Act d 11 displays the highest sequence identity with mem-
bers of the major latex protein/ripening-related protein (MLP/RRP) family, which 
belongs to the Bet v 1 superfamily.76 A lower sequence identity is shared with 
members of the PR-10 protein family, including Bet v 1.75 
Several antigenic regions of the surface of Bet v 1 and of co-recognized al-
lergens were described following studies based on the mapping of conserved 
residues,77,78 phage-displayed allergen mimotope technology79 and X-ray crys-
tallography.80 Most of the amino-acid residues, which belong to B-cell or T-cell 
epitopes in Bet v 1 or in Bet v 1-related allergens,77,81 are conserved in Act d 11 
and cluster mainly in the regions comprising the p-loop motif and the protein 
C-terminal domain, where the local sequence identity is significantly high.75  
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The residue Glu45 was reported to be critically important in Bet v 1 for IgG 
and IgE binding.81 Like several MLP/RRPs, Act d 11 shares E45 with Bet v 1 
and with most of the homologous allergens. The capacity of Act d 11 to inhibit, 
at least partially, IgE binding to Bet v 1 and to homologues, such as Cor a 1, Dau 
c 1 and Mal d 1, suggests epitope-sharing regions higher than that inferable from 
the low overall sequence identity.75 
Act d 11 showed IgE reactivity in SPT, double blind placebo-controlled food 
challenge and immunoblot. Act d 11 was able to inhibit partially Bet v 1, Mal d 1 
and Cor a 1 IgE binding. Soluble Bet v 1 achieved 100 % IgE inhibition of 
almost all Act d 11 positive sera.75 
4. CROSS-REACTIVITY BETWEEN KIWIFRUIT AND LATEX AND/OR POLLEN 
ALLERGENS 
Cross-reactivity (CR) occurs when an adaptive immune response to a parti-
cular antigen causes reactivity to other antigens that are structurally related to the 
inducer.82 The World Health Organization guidelines for the prediction of aller-
genicity specify that a protein can be considered to cross-react with an allergen if 
they share at least 35 % sequence similarity in a fragment of 80 amino acids or 
complete identity with a peptide of 6–8 amino acids from an allergen. Latex-fruit 
syndrome is the association of latex allergy and allergy to plant foods, which 
affects up to 50 % of latex-allergic patients.83 The foods most frequently in-
volved are banana (28 %), avocado (28 %), chestnut (24 %) and kiwi (20 %). 
With these foods, clinical symptoms are often severe, as is the case with other 
foods less frequently related to latex (fig, papaya and tomato). Allergy to latex 
usually precedes food allergy, although this is not always the case. Frequently, 
the spectrum of food allergies increases with time.83 
Patients allergic to pollen from birch and other Fagales show symptoms of 
allergy to plant foods. Pollinosis precedes the symptoms induced by the foods. 
These tend to be slight, characteristically OAS, and occur following ingestion of 
the raw food. The main culprit allergen, which is involved in more than 90 % of 
patients with allergy to plant foods associated with allergy to birch pollen, is Bet 
v 1,84 a PR-10, which gives rise to cross-reactivity with its homologues in these 
foods. In kiwifruit, the two Bet v 1 homologues identified so far in green and 
gold specimens are Act d 8 and Act c 8,61 but also Act d 11.75  
Profilins are structural proteins that are both ubiquitous and very well con-
served during evolution. They are considered incomplete allergens, capable of 
inducing sensitization by inhalation, but not by ingestion, due to their lability 
against peptic digestion. Thus, whilst in the north of Europe, it is associated with 
allergy to birch pollen,85 while in Spain, it is more frequent and associated 
mainly with pollinoses due to grasses.86 The clinical manifestation of this food 
allergy is OAS induced by the raw food. Several foods could be involved, given 
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that many allergenic profilins have been described in plant foods that are eaten 
raw. Profilin present in green kiwifruit extract was designated Act d 9.29 
In the study of Gavrović-Jankulović et al., a molecular basis of IgE cross-re-
activity between meadow fescue pollen and kiwifruit has been found between 
Fes p 4, a 36-kDa meadow fescue allergen and a 24-kDa kiwifruit protein.13 
5. DIAGNOSIS OF KIWIFRUIT ALLERGY  
At present, the diagnosis of kiwifruit allergy is unsatisfactory. In vitro and in 
vivo tests based on commercially available kiwifruit extracts frequently fail to 
detect specific IgE, resulting in a low sensitivity.29 Diagnosis performed by skin 
prick testing with kiwifruit extract has a sensitivity of only 40 to 50 %, while the 
measurement of food specific serum IgE has a sensitivity of 17 to 60 %.87 Due to 
the poor correlation between a suggestive case history and a skin prick test (SPT) 
performed with commercial kiwifruit protein extracts, improved in vivo diagnosis 
of kiwifruit allergy necessitates the use of fresh fruit, such as in the prick–prick 
technique. However, although prick-to-prick tests with fresh kiwifruit have a 
higher sensitivity (83 to 100 %), they also have a low specificity (31 %) and are 
difficult to standardize.12,15 The low diagnostic sensitivity of in vitro and in vivo 
tests is related to the low level or absence of kiwifruit proteins from commer-
cially available kiwifruit extracts. Preparation of higher quality extracts that would 
give reproducible results is limited by the natural variability of the plant source 
material.29 It was also shown that the natural ripening stage, cold storage, and 
ethylene treatment influence the protein composition and IgE-binding profiles of 
both green and gold kiwi fruit extracts.88,89  
Two recent studies showed that the use of individual kiwifruit allergens in-
creased the diagnostic sensitivity compared with use of commercial extracts. In a 
study by Bublin et al., the authors evaluated the use of individual allergens for 
component-resolved in vitro diagnosis of kiwifruit allergy. The study was per-
formed on thirty patients with a positive double-blind placebo-controlled food 
challenge (DBCFC) to kiwifruit. Specific IgE to 7 individual allergens and aller-
gen extracts was measured by ImmunoCAP. The use of individual allergens raised 
the diagnosis sensitivity from the 17 % obtained with commercial extract to 77 
%, but the diagnostic specificity was lowered from 100 to 30 %. Using only kiwi 
allergens Act d 1, Act d 2, Act d 4, and Act d 5 gave a diagnostic sensitivity of 
40 %, whereas diagnostic specificity remained high (90 %).29 The performance 
of a component-based allergen micro-array for the diagnosis of kiwifruit allergy 
was evaluated by Bublin et al. The specific IgE and IgG4 levels to a panel of 
nine kiwifruit allergens where measured in sera of 237 individuals with kiwifruit 
allergy. The panel of kiwifruit allergens showed a diagnostic sensitivity of 66 %, 
a specificity of 56 % and a positive predictive value of 73 %.7 
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Molecular basis of kiwifruit allergy has been extensively investigated in the 
last decade and huge progress has been made in the isolation and characterization 
of kiwifruit allergens. However, kiwifruit allergen extracts are still employed in 
clinical settings for in vivo allergy diagnosis by the skin prick test. In order to im-
prove performance of allergy diagnosis, it seems that the component-resolved 
concept with a selected panel of natural and/or recombinant kiwifruit allergens 
will replace allergen extracts in future allergy testing.  
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И З В О Д  
ПЛОД КИВИЈА КАО ИЗВОР АЛЕРГЕНА ХРАНЕ 
МИЛИЦА ПОПОВИЋ, МИЛИЦА ГРОЗДАНОВИЋ и МАРИЈА ГАВРОВИЋ-ЈАНКУЛОВИЋ 
Катедра за биохемију, Хемијски факултет, Универзитет у Београду, Београд 
Од првог појављивања на тржишту плод кивија је постао изузетно популаран сас-
тојак хумане исхране услед пријатног укуса, ниске калоријске вредности и високог садр-
жаја витамина C. Међутим, алергија на киви је постала учестали узрок преосетљивости 
типа I у западном друштву. До сада је откривено 11 IgE везујућих молекула који чине 
молекулску основу алергије на киви. То су протеини и гликопротеини молекулских маса 
између 10 и 50 kDa. Главни алерген кивија је цистеин-протеаза означена као Act d 1, 
која сачињава 50 % растворних протеина плода кивија. Услед разлике у заступљености 
протеинских компоненти и биолошкој активности, квалитет протеинских екстраката ки-
вија који се употребљавају у дијагностификовању алергије може варирати у садржају и 
количини IgE реактивних молекула. Такође, квалитет алергених екстраката зависи од 
степена зрелости воћа приликом брања, као и од услова складиштења воћа након брања. 
По питању клиничке реактивности постало је очигледно да алергија на плод кивија не 
представља хомогени поремећај. Различити обрасци IgE реактивности уочени су код не-
колицине клиничких подгрупа које су идентификоване у различитим географским реги-
јама. Током последње деценије начињен је велики напредак у изоловању и карактери-
зацији IgE везујућих протеина кивија. У оквиру овог рада даћемо преглед структурних 
особина алергених протеина кивија. 
(Примљено 12. децембра 2012, ревидирано 30. јануара 2013) 
REFERENCES 
1. K. A. Jung, T. C. Song, D. Han, I. H. Kim, Y. E. Kim, C. H. Lee, Biol. Pharm. Bull. 28 
(2005) 1782 
2. E. C. Rush, M. Patel, L. D. Plank, L. R. Ferguson, Asia Pac. J. Clin. Nutr. 11 (2002) 164 
3. J. Han, J. D. Morton, A. E. D. Bekhit, J. R. Sedcole, Meat Sci. 82 (2009) 324 
4. G. I. Katsaros, G. Tavantzis, P. S. Taoukis, Innov. Food Sci. Emerg. Technol. 11 (2010) 
47 
5. A. M. Goulal, K. G. Adamopoulos, J. Food Process. Technol. 2 (2011) 106 
6. A. J. Fine, J. Allergy Clin. Immunol. 68 (1981) 235 
7. M. Bublin, S. Dennstedt, M. Buchegger, M. Antonietta Ciardiello, M. L. Bernardi, L. 
Tuppo, C. Harwanegg, C. Hafner, C. Ebner, B. Ballmer-Weber, A. Knulst, K. Hoffmann-
Sommergruber, C. Radauer, A. Mari, H. Breiteneder, Clin. Exp. Allergy 41 (2011) 129 
__________________________________________________________________________________________________________________________
2013 Copyright (CC) SCS
Available online at shd.org.rs/JSCS/
 KIWIFRUIT ALLERGENS 349 
8. A. R. Ferguson, E. H. Wilson, Arnoldia 43 (1983) 24 
9. J. F. Morton, Kiwifruit and related species, in Fruits of warm climates, C. F. Dowling, 
Ed., J. F. Morton, Miami, Florida, USA, 1987, pp. 293 
10. N. D. Vietmeyer, National Geographic 171 (1987) 683 
11. C. Liang, A. R. Ferguson, New Zeal. J. .Bot. 24 (1986) 183 
12. J. S. Lucas, K. E. Grimshaw, K. Collins, J. O. Warner, J. O. Hourihane, Clin. Exp. Allergy 
34 (2004) 1115  
13. M. Gavrović-Jankulović, T. Ćirković, O. Vučković, M. Atanasković-Marković, A. 
Petersen, G. Gojgić, L. Burazer, R. M. Jankov, J. Allergy Clin. Immunol. 110 (2002) 805 
14. A. Palacin, J. Rodriguez, C. Blanco, G. Lopez-Torrejon, R. Sanchez-Monge, J. Varela, 
M. A. Jimenez, J. Cumplido, T. Carrillo, J. F. Crespo, G. Salcedo, Clin. Exp. Allergy 38 
(2008) 1220 
15. A. Aleman, J. Sastre, S. Quirce, M. de las Heras, J. Carnes, E. Fernandez-Caldas, C. 
Pastor, A. B. Blazquez, F. Vivanco, J. Cuesta-Herranz, J. Allergy Clin. Immunol. 113 
(2004) 543 
16. W. Paul, J. Amiss, R. Try, U. Praekelt, R. Scott, H. Smith, Plant Physiol 108 (1995) 261 
17. E. N. Baker, J. Mol. Biol. 141 (1980) 441 
18. A. Carne, C. H. Moore, Biochem. J. 173 (1978) 73 
19. E. Podivinsky, R. L. Forster, R. C. Gardner, Nucleic Acids Res. 17 (1989) 8363 
20. E. A. Pastorello, V. Pravettoni, M. Ispano, L. Farioli, R. Ansaloni, F. Rotondo, C. Incor-
vaia, I. Asman, A. Bengtsson, C. Ortolani, J. Allergy Clin. Immunol. 98 (1996) 601 
21. M. Grozdanovic, N, Polovic, O, Vuckovic, M. Atanaskovic-Markovic, B. Lindner, A. 
Petersen, M. Gavrovic-Jankulovic, Food Chem. Toxicol. 50 (2011) 1013 
22. N. J. Nieuwenhuizen, L. L. Beuning, P. W. Sutherland, N. S. Neelam, J. M. Cooney, L. 
R. Bieleski, R. Schroder, E. A. MacRae, R.G. Atkinson, Funct. Plant Biol. 34 (2007) 946 
23. A. C. Arcus, Biochim. Biophys. Acta 33 (1959) 242 
24. M. A. McDowall, Eur. J. Biochem. 14 (1970) 214 
25. U. M. Praekelt, R. A. McKee, H. Smith, Plant Mol. Biol. 10 (1988) 193 
26. L. Malone, J. Todd, E. Burgess, B. Philip, New Zeal. J. Crop Hort. Sci. 33 (2005) 99 
27. E. A. Pastorello, A. Conti, V. Pravettoni, L. Farioli, F. Rivolta, R. Ansaloni, M. Ispano, 
C. Incorvaia, M. G. Giuffrida, C. Ortolani, J. Allergy Clin. Immunol 101(1998) 531 
28. M. Bublin, A. Mari, C. Ebner, A. Knulst, O. Scheiner, K. Hoffmann-Sommergruber, H. 
Breiteneder, C. Radauer, J. Allergy Clin. Immunol. 114 (2004) 1169 
29. M. Bublin, M. Pfister, C. Radauer, C. Oberhuber, S. Bulley, A. M. Dewitt, J. Lidholm, G. 
Reese, S. Vieths, H. Breiteneder, K. Hoffmann-Sommergruber, B. Ballmer-Weber, J. 
Allergy Clin. Immunol. 125 (2010) 687 
30. J. S. Lucas, N. J. Nieuwenhuizen, R. G. Atkinson, E. A. Macrae, S. A. Cochrane, J. O. 
Warner, J. O. Hourihane, Clin. Exp. Allergy 37 (2007) 1340 
31. M. Bublin, C. Radauer, A. Knulst, S. Wagner, O. Scheiner, A. R. Mackie, E. N. Mills, H. 
Breiteneder, Mol. Nutr. Food Res. 52 (2008) 1130 
32. L. Kaur, S. M. Rutherfurd, P. J. Moughan, L. Drummond, M. J. Boland, J. Agric. Food 
Chem. 58 (2010) 5074 
33. S. M. Rutherfurd, C. A. Montoya, M. L. Zou, P. J. Moughan, L. N. Drummond, M. J. 
Boland, Food Chem. 129 (2011) 1681 
34. M. Čavić, M. Grozdanovic, A. Bajić, T. Srdić-Rajić, P. R. Anđjus, M. Gavrović-Janku-
lović, Phytochemistry 77 (2012) 46 
35. L. van Loon, W. Pierpoint, T. Boller, V. Conejero, Plant Mol. Biol. Rep. 12 (1994) 245 
36. H. Wang, T. B. Ng, Phytochemistry 61 (2002) 1 
__________________________________________________________________________________________________________________________
2013 Copyright (CC) SCS
Available online at shd.org.rs/JSCS/
350 POPOVIĆ, GROZDANOVIĆ and GAVROVIĆ-JANKULOVIĆ 
37. G. del Val, B. C. Yee, R. M. Lozano, B. B. Buchanan, R. W. Ermel, Y. M. Lee, O. L. 
Frick, J. Allergy Clin. Immunol. 103 (1999) 690 
38. B. B. Buchanan, C. Adamidi, R. M. Lozano, B. C. Yee, M. Momma, K. Kobrehel, R. 
Ermel, O. L. Frick, Proc Natl. Acad. Sci. USA 94 (1997) 5372 
39. R. Kaneko, N. Kitabatake, J. Agric. Food Chem. 47 (1999) 4950 
40. D. B. Volkin, A. M. Klibanov, J. Biol. Chem. 262 (1987) 2945 
41. M. Bublin, C. Radauer, A. Lebens, A. Knulst, O. Scheiner, H. Breiteneder, XXV Congress 
European Academy of Allergy and Clinical Immunology EAACI, Abstract book, 2006, 
pp. 148 
42. M. Rassam, W. A. Laing, Phytochemistry 65 (2004) 19 
43. M. M. Popovic, M. Milovanovic, L. Burazer, O. Vuckovic, K. Hoffmann-Sommergruber, 
A. C. Knulst, B. Lindner, A. Petersen, R. Jankov, M. Gavrovic-Jankulovic, Mol. Nutr. 
Food Res. 54 (2010) 373 
44. M. M. Popovic, A. Bulajic, D. Ristic, B. Krstic, R. M. Jankov, M. Gavrovic-Jankulovic, 
J. Sci. Food Agric. 92 (2012) 3072 
45. M. Popovic, U. Andjelkovic, M. Grozdanovic, I. Aleksic, M. Gavrovic-Jankulovic, In-
dian J. Microbiol. 53 (2013) 100 
46. M. Tamburrini, I. Cerasuolo, V. Carratore, A. Stanziola, S. Zofra, L. Romano, L. Camar-
della, M. A. Ciardiello, Protein J. 24 (2005) 423 
47. L. Tuppo, I. Giangrieco, P. Palazzo, M. L. Bernardi, E. Scala, V. Carratore, M. Tambur-
rini, A. Mari, M. A. Ciardiello, J. Agric. Food Chem. 56 (2008) 3812 
48. M. A. Ciardiello, D. Meleleo, G. Saviano, R. Crescenzo, V. Carratore, L. Camardella, E. 
Gallucci, S. Micelli, T. Tancredi, D. Picone, M. Tamburrini, J. Pept. Sci. 14 (2008) 742 
49. K. Thevissen, A. Ghazi, G. W. De Samblanx, C. Brownlee, R. W. Osborn, W. F. 
Broekaert, J. Biol. Chem. 271 (1996) 15018 
50. M. Wu, E. Maier, R. Benz, R. E. Hancock, Biochemistry 38 (1999) 7235 
51. M. L. Bernardi, D. Picone, L. Tuppo, I. Giangrieco, G. Petrella, P. Palazzo, R. Ferrara, M. 
Tamburrini, A. Mari, M. A. Ciardiello, Clin. Exp. Allergy 40 (2010) 1819 
52. L. Camardella, V. Carratore, M. A. Ciardiello, L. Servillo, C. Balestrieri, A. Giovane, 
Eur. J. Biochem. 267 (2000) 4561 
53. K. Irifune, T. Nishida, H. Egawa, A. Nagatani, Plant Cell Rep. 23 (2004) 333 
54. A. K. Handa, D. M. Tieman, K. K. Mishra, B. R. Thakur, R. K. Singh, in Progress in 
Biotechnology: Pectins and Pectinases, Proceedings of an International Symposium, 
Wageningen, The Netherlands, 1995, J. Visser, A. G. J. Voragen, Eds., Elsevier, 
Amsterdam, 1996, pp. 355–368 
55. M. Fries, J. Ihrig, K. Brocklehurst, V. E. Shevchik, R. W. Pickersgill, EMBO J. 26 (2007) 
3879 
56. M. A. Ciardiello, R. D'Avino, A. Amoresano, L. Tuppo, A. Carpentieri, V. Carratore, M. 
Tamburrini, A. Giovane, P. Pucci, L. Camardella, Proteins 71 (2008) 195 
57. A. Giovane, L. Quagliuolo, D. Castaldo, L. Servillo, C. Balestrieri, Phytochemistry 29 
(1990) 2821 
58. M. A. Ciardiello, M. Tamburrini, L. Tuppo, V. Carratore, A. Giovane, B. Mattei, L. Ca-
mardella, J. Agric. Food Chem. 52 (2004) 7700 
59. F. Altmann, Int. Arch. Allergy Immunol. 142 (2007) 99 
60. S. Elsayed, H. Vik, Int. Arch. Allergy Appl. Immunol. 93 (1990) 378 
61. C. Oberhuber, S. M. Bulley, B. K. Ballmer-Weber, M. Bublin, S. Gaier, A. M. DeWitt, P. 
Briza, G. Hofstetter, J. Lidholm, S. Vieths, K. Hoffmann-Sommergruber, Mol. Nutr. Food 
Res. 52 (2008) S230 
__________________________________________________________________________________________________________________________
2013 Copyright (CC) SCS
Available online at shd.org.rs/JSCS/
 KIWIFRUIT ALLERGENS 351 
62. M. Fernandez-Rivas, S. Bolhaar, E. Gonzalez-Mancebo, R. Asero, A. van Leeuwen, B. 
Bohle, Y. Ma, C. Ebner, N. Rigby, A. I. Sancho, S. Miles, L. Zuidmeer, A. Knulst, H. 
Breiteneder, C. Mills, K. Hoffmann-Sommergruber, R. van Ree, J. Allergy Clin. Im-
munol. 118 (2006) 481 
63. B. K. Ballmer-Weber, S. Scheurer, P. Fritsche, E. Enrique, A. Cistero-Bahima, T. Haase, 
B. Wuthrich, J. Allergy Clin. Immunol. 110 (2002) 167 
64. M. Geroldinger-Simic, T. Zelniker, W. Aberer, C. Ebner, C. Egger, A. Greiderer, N. 
Prem, J. Lidholm, B. K. Ballmer-Weber, S. Vieths, B. Bohle, J. Allergy Clin. Immunol. 
127 (2011) 616 
65. L. Carlsson, L. E. Nyström, I. Sundkvist, F. Markey, U. Lindberg, J. Mol. Biol. 115 
(1977) 465 
66. A. Di Nardo, R. Gareus, D. Kwiatkowski, W. Witke, J. Cell Sci. 113 (2000) 3795 
67. T. Domke, T. Federau, K. Schluter, K. Giehl, R. Valenta, D. Schomburg, B. M. Jockusch, 
FEBS Lett. 411 (1997) 291 
68. R. Asero, G. Mistrello, D. Roncarolo, S. Amato, Int. Arch. Allergy Immunol. 133 (2004) 
121 
69. S. Scheurer, A. Wangorsch, J. Nerkamp, P. S. Skov, B. Ballmer-Weber, B. Wuthrich, D. 
Haustein, S. Vieths, J. Chromatogr. B 756 (2001) 315 
70. C. Ebner, R. Hirschwehr, L. Bauer, H. Breiteneder, R. Valenta, H. Ebner, D. Kraft, O. 
Scheiner, J. Allergy Clin. Immunol. 95 (1995) 962 
71. M. Moller, M. Kayma, D. Vieluf, A. Paschke, H. Steinhart, Allergy 53 (1998) 289 
72. M. L. Bernardi, I. Giangrieco, L. Camardella, R. Ferrara, P. Palazzo, M. R. Panico, R. 
Crescenzo, V. Carratore, D. Zennaro, M. Liso, M. Santoro, S. Zuzzi, M. Tamburrini, M. 
A. Ciardiello, A. Mari, PLoS One 6 (2011) e27856 
73. T. H. Yeats, J. K. Rose, Protein Sci. 17 (2008) 191 
74. V. Cavatorta, S. Sforza, G. Aquino, G. Galaverna, A. Dossena, E. A. Pastorello, R. 
Marchelli, Mol. Nutr. Food Res. 54 (2010) 1452 
75. R. D'Avino, M. L. Bernardi, M. Wallner, P. Palazzo, L. Camardella, L. Tuppo, C. Ales-
sandri, H. Breiteneder, F. Ferreira, M. A. Ciardiello, A. Mari, Allergy 66 (2011) 870 
76. C. Radauer, H. Breiteneder, J. Allergy Clin. Immunol. 120 (2007) 518 
77. F. Ferreira, C. Ebner, B. Kramer, G. Casari, P. Briza, A. J. Kungl, R. Grimm, B. Jahn-
Schmid, H. Breiteneder, D. Kraft, M. Breitenbach, H. J. Rheinberger, O. Scheiner, 
FASEB J. 12 (1998) 231 
78. A. Wangorsch, B. K. Ballmer-Weber, P. Rosch, T. Holzhauser, S. Vieths, Mol. Immunol. 
44 (2007) 2518 
79. E. Jensen-Jarolim, A. Leitner, H. Kalchhauser, A. Zurcher, E. Ganglberger, B. Bohle, O. 
Scheiner, G. Boltz-Nitulescu, H. Breiteneder, FASEB J. 12 (1998) 1635 
80. E. Ganglberger, K. Grunberger, B. Sponer, C. Radauer, H. Breiteneder, G. Boltz-
Nitulescu, O. Scheiner, E. Jensen-Jarolim, FASEB J. 14 (2000) 2177 
81. T. Schirmer, K. Hoffimann-Sommergrube, M. Susani, H. Breiteneder, Z. Markovic-Hous-
ley, J. Mol. Biol. 351 (2005) 1101 
82. R. S. Bonds, T. Midoro-Horiuti, R. Goldblum, Curr. Opin. Allergy Clin. Immunol. 8 
(2008) 82 
83. C. Blanco, T. Carrillo, R. Castillo, J. Quiralte, M. Cuevas, Ann. Allergy 73 (1994) 309 
84. K. Hoffmann-Sommergruber, C. Radauer, in Plant Food Allergens, Ch. 8, E. N. C. Mills, 
P. R. Shewry Eds., Blackwell Publishing, Oxford, UK 2007, p. 125  
85. M. Egger, S. Mutschlechner, N. Wopfner, G. Gadermaier, P. Briza, F. Ferreira, Allergy 
61 (2006) 461 
__________________________________________________________________________________________________________________________
2013 Copyright (CC) SCS
Available online at shd.org.rs/JSCS/
352 POPOVIĆ, GROZDANOVIĆ and GAVROVIĆ-JANKULOVIĆ 
86. D. Barber, F. De La Torre, F. Feo, F. Florido, P. Guardia, C. Moreno, J. Quiralte, M. 
Lombardero, M. Villalba, G. Salcedo, R. Rodríguez, Allergy 63 (2008) 1550 
87. T.M. Le, M. Bublin, H. Breiteneder, M. Fernández-Rivas, R. Asero, B. Ballmer-Weber, 
L. Barreales, P. Bures, S. Belohlavkova, F. de Blay, M. Clausen, R. Dubakiene, D. 
Gislason, E. van Hoffen, M. Jedrzejczak-Czechowicz, M. L. Kowalski, T. Kralimarkova, 
J. Lidholm, A. M. Dewitt, C. E. Mills, N. G. Papadopoulos, T. Popov, A Purohit, R. van 
Ree, S. Seneviratne, A. Sinaniotis, C. Summers, S. Vázquez-Cortés, S. Vieths, L. Vogel, 
K. Hoffmann-Sommergruber, A. C. Knulst, J. Allergy Clin. Immunol. 131 (2013) 164 
88. M. A. Ciardiello, I. Giangrieco, L. Tuppo, M. Tamburrini, M. Buccheri, P. Palazzo, M. L. 
Bernardi, R. Ferrara, A. Mari. J. Agric. Food Chem. 57 (2009) 1565 
89. M. Gavrovic-Jankulovic, N. Polovic, S. Prisic, R. Jankov, M. Atanaskovic-Markovic, O. 
Vuckovic, T. C. Velickovic, Food Agric. Immunol. 16 (2005) 117. 
__________________________________________________________________________________________________________________________
2013 Copyright (CC) SCS
Available online at shd.org.rs/JSCS/
